OBJECTIVES: The aim of this study was to quantify acute myocardial retention of cardiac-derived stem cells (CDCs) and evaluate different delivery methods with positron emission tomography (PET). BACKGROUND: Success of stem cell transplantation for cardiac regeneration is partially limited by low retention/engraftment of the delivered cells. A clinically applicable method for accurate quantification of cell retention would enable optimization of cell delivery. METHODS: The CDCs were derived from syngeneic, male Wistar Kyoto (WK) rats labeled with [(18)F]-fluoro-deoxy-glucose ((18)FDG) and injected intramyocardially into the ischemic region of female WK rats after permanent left coronary artery ligation. The effects of fibrin glue (FG), bradycardia (adenosine), and cardiac arrest were examined. Imaging with (18)FDG PET was performed for quantification of cell retention. Quantitative polymerase chain reaction (PCR) for the male-specific SRY gene was performed to validate the PET results. RESULTS: Myocardial retention of cells suspended in phosphate-buffered saline 1 h after delivery was 17.6 +/- 11.5% by PCR and 17.8 +/- 7.3% by PET. When CDCs were injected immediately after induction of cardiac arrest, retention was increased to 75.6 +/- 18.6%. Adenosine slowed the ventricular rate and doubled CDC retention (35.4 +/- 5.3%). A similar increase in CDC retention was observed after epicardial application of FG at the injection site (37.5 +/- 8.2%). The PCR revealed a significant increase in 3-week cell engraftment in the FG animals (22.1 +/- 18.6% and 5.3 +/- 3.1%, for FG and phosphate-buffered saline, respectively). CONCLUSIONS: In vivo PET permits accurate measurement of CDC retention early after intramyocardial delivery. Sealing injection sites with FG or lowering ventricular rate by adenosine might be clinically translatable methods for improving stem cell engraftment in a beating heart.
OBJECTIVES: The aim of this study was to quantify acute myocardial retention of cardiac-derived stem cells (CDCs) and evaluate different delivery methods with positron emission tomography (PET). BACKGROUND: Success of stem cell transplantation for cardiac regeneration is partially limited by low retention/engraftment of the delivered cells. A clinically applicable method for accurate quantification of cell retention would enable optimization of cell delivery. METHODS: The CDCs were derived from syngeneic, male Wistar Kyoto (WK) rats labeled with [(18)F]-fluoro-deoxy-glucose ((18)FDG) and injected intramyocardially into the ischemic region of female WK rats after permanent left coronary artery ligation. The effects of fibrin glue (FG), bradycardia (adenosine), and cardiac arrest were examined. Imaging with (18)FDG PET was performed for quantification of cell retention. Quantitative polymerase chain reaction (PCR) for the male-specific SRY gene was performed to validate the PET results. RESULTS: Myocardial retention of cells suspended in phosphate-buffered saline 1 h after delivery was 17.6 +/- 11.5% by PCR and 17.8 +/- 7.3% by PET. When CDCs were injected immediately after induction of cardiac arrest, retention was increased to 75.6 +/- 18.6%. Adenosine slowed the ventricular rate and doubled CDC retention (35.4 +/- 5.3%). A similar increase in CDC retention was observed after epicardial application of FG at the injection site (37.5 +/- 8.2%). The PCR revealed a significant increase in 3-week cell engraftment in the FG animals (22.1 +/- 18.6% and 5.3 +/- 3.1%, for FG and phosphate-buffered saline, respectively). CONCLUSIONS: In vivo PET permits accurate measurement of CDC retention early after intramyocardial delivery. Sealing injection sites with FG or lowering ventricular rate by adenosine might be clinically translatable methods for improving stem cell engraftment in a beating heart.
Authors: Valeri Chekanov; Massod Akhtar; Guennady Tchekanov; George Dangas; Muhammad Z Shehzad; Fermin Tio; Milena Adamian; Antonio Colombo; Gary Roubin; Martin B Leon; Jeffrey W Moses; Nicholas N Kipshidze Journal: Pacing Clin Electrophysiol Date: 2003-01 Impact factor: 1.976
Authors: Nona Adonai; Nora Adonai; Khoi N Nguyen; Joseph Walsh; M Iyer; Tatsushi Toyokuni; Michael E Phelps; Timothy McCarthy; Deborah W McCarthy; Sanjiv Sam Gambhir Journal: Proc Natl Acad Sci U S A Date: 2002-02-26 Impact factor: 11.205
Authors: Winfried Brenner; Alexandra Aicher; Thomas Eckey; Schirin Massoudi; Maaz Zuhayra; Ulrike Koehl; Christopher Heeschen; Willm U Kampen; Andreas M Zeiher; Stefanie Dimmeler; Eberhard Henze Journal: J Nucl Med Date: 2004-03 Impact factor: 10.057
Authors: Joseph C Wu; Ian Y Chen; Gobalakrishnan Sundaresan; Jung-Joon Min; Abhijit De; Jian-Hua Qiao; Michael C Fishbein; Sanjiv S Gambhir Journal: Circulation Date: 2003-09-08 Impact factor: 29.690
Authors: Michael Bonios; Connie Y Chang; Aurelio Pinheiro; Veronica Lea Dimaano; Takahiro Higuchi; Christina Melexopoulou; Frank Bengel; John Terrovitis; Theodore P Abraham; M Roselle Abraham Journal: J Am Soc Echocardiogr Date: 2011-04-20 Impact factor: 5.251
Authors: James D Richardson; Adam J Nelson; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley; Peter J Psaltis Journal: Stem Cell Rev Rep Date: 2013-06 Impact factor: 5.739
Authors: Angel T Chan; Mehmet F Karakas; Styliani Vakrou; Junaid Afzal; Andrew Rittenbach; Xiaoping Lin; Richard L Wahl; Martin G Pomper; Charles J Steenbergen; Benjamin M W Tsui; Jennifer H Elisseeff; M Roselle Abraham Journal: Biomaterials Date: 2015-09-04 Impact factor: 12.479
Authors: Ann C Gaffey; Minna H Chen; Chantel M Venkataraman; Alen Trubelja; Christopher B Rodell; Patrick V Dinh; George Hung; John W MacArthur; Renganaden V Soopan; Jason A Burdick; Pavan Atluri Journal: J Thorac Cardiovasc Surg Date: 2015-07-17 Impact factor: 5.209
Authors: Anna V Naumova; Niranjan Balu; Vasily L Yarnykh; Hans Reinecke; Charles E Murry; Chun Yuan Journal: J Cardiovasc Pharmacol Ther Date: 2014-03-30 Impact factor: 2.457
Authors: Eric G Schmuck; Jacob D Mulligan; Rebecca L Ertel; Nicholas A Kouris; Brenda M Ogle; Amish N Raval; Kurt W Saupe Journal: Cardiovasc Eng Technol Date: 2014-03-01 Impact factor: 2.495